GlassScriptPhysician profile
Raad E Jajo
NPI 1497813471
$1,908.70
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,304 · 2020: $604.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $814.61 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $250.37 | 2019 | |
| Lundbeck LLC | $145.70 | 2019-2020 | |
| Allergan, INC. | $135.59 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $119.62 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $66.28 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $64.51 | 2019-2020 | |
| Alkermes, INC. | $45.65 | 2019 | |
| Janssen Pharmaceuticals, INC | $43.18 | 2019-2020 | |
| Shire North American Group INC | $41.50 | 2019 | |
| Ironshore Pharmaceuticals INC. | $33.75 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.71 | 2020 | |
| Vanda Pharmaceuticals INC. | $19.72 | 2019 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $19.68 | 2019 | |
| Indivior INC. | $19.07 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $16.52 | 2019 | |
| Neos Therapeutics, LP | $13.44 | 2019 | |
| Pfizer INC. | $13.07 | 2019 | |
| Bausch Health US, LLC | $13.03 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.70 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raad Jajo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.